US 7759106
Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli
granted A61KA61K2039/522A61K2039/523
Quick answer
US patent 7759106 (Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/522, A61K2039/523, A61K2039/543, A61K2039/70